February 27, 2023 — 04:09 pm EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Below are the earnings highlights for Biomarin Pharmaceutical Inc. (BMRN):
Earnings: -$0.2 million in Q4 vs. -$57.9 million in the same period last year. 
EPS: -$0.00 in Q4 vs. -$0.32 in the same period last year. 
Analysts projected -$0.07 per share 
Revenue: $537.5 million in Q4 vs. $449.8 million in the same period last year.
 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.